Attention deficit hyperactivity disorder is a disease of the brain, previously known as attention deficit disorder. It is one of the most general mental disorders affecting children as well as adults. Attention deficit hyperactivity disorder is when the patient has difficulty sitting still, focusing on tasks, and paying attention. The patient with this disorder acts without thinking. This disease can be diagnosed between the age of 6 and 12 years. The growing number of pre-term births of babies is a fueling factor for the attention deficit hyperactivity disorder market growth. The University of Maryland Medical Center (UMMC) predicts that 20% of prematurely born babies have this disorder. The rising trend of pregnant women of toxins such as alcohol, cigarette, and drugs result in children born with attention deficit hyperactivity disorder. Complementary and alternative therapies such as vitamins, special diets, minerals, and herbs may hamper the attention deficit hyperactivity disorder market growth during the forecast period. The Attention Deficit Hyperactivity Market is expected to grow at the rate of 8.4% CAGR by 2026.

View Complete Report: @https://www.infoholicresearch.com/report/attention-deficit-hyperactivity-market/

Attention Deficit Hyperactivity Market based on Drug Type
Stimulant
Non-stimulant
Attention Deficit Hyperactivity Market based on Demographic
Adult (Aged 18 and above)
Children
Attention Deficit Hyperactivity Market based on Distribution Channel
Retail Pharmacy
Hospital Pharmacy
Attention Deficit Hyperactivity Market based on Geography
North America
Europe
Asia Pacific
Rest of the World
The attention deficit hyperactivity market is bifurcated into stimulant and non-stimulant based on drug type. The stimulant drug type has a significant share in the attention deficit hyperactivity market. The major share is due to the huge demand for these drugs due to their effectiveness in treating attention deficit hyperactivity disorder symptoms. Ongoingclinical trials and government provision for the use of stimulants to treat mental health disorders are other factors driving the segment’s growth.

Request a Sample of this Report: @https://www.infoholicresearch.com/request-a-sample-report/?repid=14733

Contact Us:
Infoholic Research LLP
No. 15/1, Ground floor,
9th Main Road,
Hampi Nagar, Bangalore - 560040, India
[email protected]
[email protected]